Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
Upturn AI SWOT - About
AdvisorShares Pure US Cannabis ETF (MSOS)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
10/24/2025: MSOS (1-star) is a SELL. SELL since 1 days. Simulated Profits (-12.04%). Updated daily EoD!
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Analysis of Past Performance
Type ETF | Historic Profit -51.59% | Avg. Invested days 20 | Today’s Advisory SELL |
Upturn Star Rating | Upturn Advisory Performance  2.0 | ETF Returns Performance  1.0 |
| Profits based on simulation | Last Close 10/24/2025 |
Key Highlights
Volume (30-day avg) - | Beta 1.16 | 52 Weeks Range 2.02 - 8.19 | Updated Date 06/30/2025 |
52 Weeks Range 2.02 - 8.19 | Updated Date 06/30/2025 |
Upturn AI SWOT
AdvisorShares Pure US Cannabis ETF
ETF Overview
Overview
The AdvisorShares Pure US Cannabis ETF (MSOS) focuses on providing exposure to U.S. cannabis companies, including those directly involved in the cultivation, distribution, and sale of cannabis in states where it is legal. It seeks capital appreciation by investing primarily in domestic cannabis equity securities.
Reputation and Reliability
AdvisorShares is known for offering actively managed ETFs, some with specific thematic exposures. They have a mixed reputation, as actively managed funds' performance can vary significantly.
Management Expertise
AdvisorShares employs experienced portfolio managers to actively manage the ETF's holdings based on their analysis of the U.S. cannabis industry.
Investment Objective
Goal
The ETF aims for long-term capital appreciation by investing in U.S. cannabis companies.
Investment Approach and Strategy
Strategy: Actively managed ETF focusing on companies that derive a significant portion of their revenue from the U.S. cannabis industry.
Composition Primarily holds stocks of U.S. cannabis companies.
Market Position
Market Share: Information unavailable. Cannabis ETF market shares fluctuate and are highly dependent on recent performance and fund flows.
Total Net Assets (AUM): 235000000
Competitors
Key Competitors
- MJUS
- YOLO
- CNBS
Competitive Landscape
The U.S. cannabis ETF market is relatively concentrated, with a few key players. MSOS has strong brand recognition and was one of the first to focus exclusively on US cannabis companies. Competitors often have higher expense ratios or broader investment mandates, which can be both advantages and disadvantages depending on market conditions.
Financial Performance
Historical Performance: Data not readily available. Historical performance would need to be gathered from financial data providers.
Benchmark Comparison: Difficult to compare to a specific benchmark as the U.S. cannabis market is unique and lacks a widely accepted index. Performance is best compared against other U.S. cannabis ETFs.
Expense Ratio: 0.74
Liquidity
Average Trading Volume
The ETF exhibits moderate liquidity, though its trading volume can vary depending on investor interest in the cannabis sector.
Bid-Ask Spread
The bid-ask spread is generally reasonable, but can widen during periods of high volatility or low trading volume.
Market Dynamics
Market Environment Factors
Performance is highly dependent on regulatory changes, state-level legalization efforts, and shifts in public sentiment toward cannabis. Economic factors also play a role, especially consumer discretionary spending.
Growth Trajectory
The ETF's growth trajectory is linked to the overall expansion of the U.S. cannabis market and is affected by regulatory and legislative changes.
Moat and Competitive Advantages
Competitive Edge
MSOS has been known for being one of the first ETFs providing concentrated exposure to U.S. cannabis companies, which resonates with investors seeking pure-play exposure. It has a proven track record with significant Assets Under Management (AUM). The management team employs active strategies, providing opportunities to outperform the overall market. Their active management allows for adjustments based on changing regulatory environments and market conditions, potentially capitalizing on emerging opportunities within the sector.
Risk Analysis
Volatility
The ETF is subject to high volatility due to the speculative nature of the cannabis industry and regulatory uncertainty.
Market Risk
Significant market risk associated with regulatory changes, competition, and fluctuations in consumer demand for cannabis products.
Investor Profile
Ideal Investor Profile
Suitable for investors with a high-risk tolerance who are seeking exposure to the potential growth of the U.S. cannabis industry.
Market Risk
Best suited for long-term investors who are comfortable with significant volatility and regulatory risk.
Summary
The AdvisorShares Pure US Cannabis ETF (MSOS) provides investors with exposure to the U.S. cannabis market. It is actively managed and subject to high volatility due to the regulatory uncertainty and speculative nature of the industry. The ETF may be appropriate for investors with high risk tolerance and a long-term investment horizon. While it was initially known for concentrated pure-play exposure, competitors now offer alternatives with similar characteristics, potentially impacting its market share. Investors should consider other U.S. cannabis ETFs and their investment goals before investing.
Peer Comparison
Sources and Disclaimers
Data Sources:
- AdvisorShares website
- ETF.com
- Morningstar
- Bloomberg
Disclaimers:
The data provided is for informational purposes only and should not be considered financial advice. Investment decisions should be made based on your own research and consultation with a qualified financial advisor. Past performance is not indicative of future results.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About AdvisorShares Pure US Cannabis ETF
Exchange NYSE ARCA | Headquaters - | ||
IPO Launch date - | CEO - | ||
Sector - | Industry - | Full time employees - | Website |
Full time employees - | Website | ||
The fund is an actively managed ETF that seeks to achieve its investment objective by investing, under normal circumstances, at least 80% of its net assets (plus any borrowings for investment purposes) in securities of companies that derive at least 50% of their net revenue from the marijuana and hemp business in the United States and in derivatives that have economic characteristics similar to such securities. It will concentrate at least 25% of its investments in the pharmaceuticals, biotechnology & life sciences industry group within the health care sector. The fund is non-diversified.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.